Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
4
×
clinical trials
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
4
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
europe blog main
europe top stories
fda
merck
startups
vir biotechnology
abbvie
akouos
allergan
alnylam pharmaceuticals
alzheimer's disease
What
bio
roundup
4
×
acquisitions
advantages
alliance
announced
bar
black
brings
bristol
buy
calls
ceo
changing
collabs
color
companies
continue
covid
crispr
daniel
days
deal
debut
diamond
diamond’s
drug
expect
gamble
gilead
gilead’s
growing
help
hours
indication
introduce
ipo
kudos
leading
leaves
Language
unset
4
×
Current search:
roundup
×
cancer
×
unset
×
" national top stories "
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone